In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
This content type () is not supported by this display view


A Horizon 2020 funded project to improve the prevention and treatment of Atrial Fibrillation

If you're involved in the management of patients with Atrial Fibrillation, then you’ll want to know more about CATCH ME – an exciting project that brings together the expertise of leading academic institutes, healthcare organisations and specialised professional organizations, with the aim of improving the care of patients with AFib.

Why the focus on Atrial Fibrillation?

Atrial Fibrillation (AFib) is the most common cardiac arrhythmia. A major cause of death, stroke and long-term disability in the elderly in Europe, it is a major threat to healthy ageing.

What is CATCH ME?

CATCH ME (Characterising Afib by Translating its Causes into Health Modifiers in the Elderly) aims to improve the prevention and treatment of atrial fibrillation and its complications. The goal is to develop and validate better disease management strategies based on the improved understanding of the main health modifiers (such as genes, drugs, and behaviour) leading to atrial fibrillation in the European population. More specifically, CATCH ME will:


  1. Identify the major health modifiers causing AF in the Elderly in Europe,
  2. Develop clinical tools that will personalise the prevention and management of AF patients, and
  3. Guide and strengthen future strategies to prevent, diagnose, and treat AF in Europe.

CATCH ME also aims to provide substantial answers to current AF uncertainties such as gender differences by clarifying the reasons why female European citizens seem to be protected more against AF compared to males, or why females are at higher stroke risk than males once they have developed AF.


As a consortium partner the ESC will use its expertise in translating scientific knowledge into practical tools that support health care professionals in keeping up to date and applying best practice guidelines. By using our extensive network of institutional and individual members, we ensure that these tools are delivered to the maximum number of health care professionals. These include two new mobile apps and an education programme that will revolutionise the management of patients with AFib.

NEW mobile apps

2017-07-05 - HR icon - AF manager - RGB.jpgThe 'AF Manger' app is a state-of-the-art tool for healthcare professionals that uses integrated patient data to suggest treatment options from the ESC Clinical Practice Guidelines on Atrial Fibrillation 2016.


2017-07-05 - HR icon - My AF - RGB.jpgThe 'My AF app' is an educational resource and tool for people with Atrial Fibrillation, that records symptoms and quality of life data, that can be shared with the healthcare team before each hospital visit.


Discover the apps

Online education programme

Access a range of educational materials to make the most out of/ or enhance your knowledge about these exciting new apps.

Access education programme

You may also be interested in

CATCH ME Consortium:

To find out more about CATCH ME, visit

  • The University Of Birmingham          
  • Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
  • Universiteit Maastricht           
  • Ludwig-Maximilians-Universitaet Muenchen
  • The Chancellor, Masters and Scholars of the University Of Oxford            
  • Universite Pierre Et Marie Curie - Paris 6     
  • Kompetenznetz Vorhofflimmern E.V.             
  • European Society of Cardiology ESC

N.B. CATCH ME is funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633196